Search Results - "Andrianarisoa, Meja"
-
1
Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset
Published in Schizophrenia research (01-04-2017)“…Abstract Objective The Medication Adherence Rating Scale (MARS) is one of the most widely used measurements of adherence in schizophrenia (SZ). However, the…”
Get full text
Journal Article -
2
Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort
Published in British journal of psychiatry (01-08-2018)“…Major depressive disorder (MDD) is underdiagnosed and undertreated in schizophrenia, and has been strongly associated with impaired quality of life.AimsTo…”
Get full text
Journal Article -
3
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
Published in Schizophrenia bulletin (01-09-2016)“…Inflammation, measured by abnormal blood C-reactive protein (CRP) level, has been described in schizophrenia (SZ), being inconsistently related to impaired…”
Get full text
Journal Article -
4
Early and very early‐onset schizophrenia compared with adult‐onset schizophrenia: French FACE‐SZ database
Published in Brain and behavior (01-02-2020)“…Objective To compare the clinical symptomatology in patients with Early‐Onset Schizophrenia (EOS, N = 176), especially the subgroup Very Early Onset…”
Get full text
Journal Article -
5
Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder
Published in Journal of clinical psychopharmacology (01-10-2014)Get full text
Journal Article -
6
Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort
Published in The journal of clinical psychiatry (08-01-2019)“…Extrapyramidal side effects (EPS) have been identified as a complication of antipsychotic treatment. Previous meta-analyses have investigated EPS prevalence…”
Get full text
Journal Article -
7
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort
Published in The journal of clinical psychiatry (18-09-2018)“…Predicting relapse is a major challenge in schizophrenia from a clinical and medico-economic point of view. During recent decades, major psychiatric disorders…”
Get full text
Journal Article -
8
Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort
Published in Progress in neuro-psychopharmacology & biological psychiatry (13-07-2018)“…Little is known about perception of physical pain in schizophrenia (SZ). Some studies have suggested that patients with SZ may have an increased pain…”
Get full text
Journal Article -
9
Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics
Published in The journal of clinical psychiatry (08-01-2019)“…Background: Extrapyramidal side effects (EPS) have been identified as a complication of antipsychotic treatment. Previous meta-analyses have investigated EPS…”
Get full text
Journal Article -
10
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia
Published in The journal of clinical psychiatry (18-09-2018)Get full text
Journal Article -
11
Hypovitaminosis D is associated with depression and anxiety in schizophrenia: results from the national FACE-SZ cohort. Running title: hypovitaminosis D, depression and anxiety in schizophrenia
Published in Psychiatry research (01-12-2018)“…ObjectiveHypovitaminosis D has been associated with respectively major depressive disorder, schizophrenia (SZ) and cognitive disorders in the general…”
Get full text
Journal Article -
12
Échelles d’évaluation du risque suicidaire chez les sujets âgés : revue de la littérature
Published in Annales médico psychologiques (01-05-2018)“…Le suicide concerne toutes les tranches d’âges et les sujets âgés sont parmi les plus touchés en termes de mortalité. Dépister et évaluer le risque suicidaire…”
Get full text
Journal Article -
13
Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set
Published in European archives of psychiatry and clinical neuroscience (01-02-2018)“…Objective The effect of benzodiazepine long-term administration (BLTA) in cognitive functioning of subjects with schizophrenia (SZ) has been partially explored…”
Get full text
Journal Article -
14
Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ)
Published in Progress in neuro-psychopharmacology & biological psychiatry (08-06-2019)“…Existing staging models have not been fully validated. Thus, after classifying patients with schizophrenia according to the staging model proposed by McGorry…”
Get full text
Journal Article -
15
Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort
Published in Psychiatry research (01-12-2018)“…•Beyond its role in bone metabolism, vitamin D has been shown to have multiple functions including a role in depression and cognitive impairment in general…”
Get full text
Journal Article -
16